BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17724075)

  • 1. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis.
    Kamath AT; Hanke T; Briscoe H; Britton WJ
    Immunology; 1999 Apr; 96(4):511-6. PubMed ID: 10233735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.
    Mollenkopf HJ; Grode L; Mattow J; Stein M; Mann P; Knapp B; Ulmer J; Kaufmann SH
    Infect Immun; 2004 Nov; 72(11):6471-9. PubMed ID: 15501778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
    McShane H; Brookes R; Gilbert SC; Hill AV
    Infect Immun; 2001 Feb; 69(2):681-6. PubMed ID: 11159955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.
    Chatterjee S; Dwivedi VP; Singh Y; Siddiqui I; Sharma P; Van Kaer L; Chattopadhyay D; Das G
    PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.
    Kamath AT; Feng CG; Macdonald M; Briscoe H; Britton WJ
    Infect Immun; 1999 Apr; 67(4):1702-7. PubMed ID: 10085007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice.
    Khan A; Sayedahmed EE; Singh VK; Mishra A; Dorta-Estremera S; Nookala S; Canaday DH; Chen M; Wang J; Sastry KJ; Mittal SK; Jagannath C
    Cell Rep Med; 2021 Aug; 2(8):100372. PubMed ID: 34467249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes.
    Kamath AT; Groat NL; Bean AG; Britton WJ
    Clin Exp Immunol; 2000 Jun; 120(3):476-82. PubMed ID: 10844526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 19-kD antigen and protective immunity in a murine model of tuberculosis.
    Yeremeev VV; Lyadova IV; Nikonenko BV; Apt AS; Abou-Zeid C; Inwald J; Young DB
    Clin Exp Immunol; 2000 May; 120(2):274-9. PubMed ID: 10792376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family.
    Dillon DC; Alderson MR; Day CH; Lewinsohn DM; Coler R; Bement T; Campos-Neto A; Skeiky YA; Orme IM; Roberts A; Steen S; Dalemans W; Badaro R; Reed SG
    Infect Immun; 1999 Jun; 67(6):2941-50. PubMed ID: 10338503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.
    Feng G; Jiang Q; Xia M; Lu Y; Qiu W; Zhao D; Lu L; Peng G; Wang Y
    PLoS One; 2013; 8(4):e61135. PubMed ID: 23637790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant BCG as a vaccine vehicle to protect against tuberculosis.
    Triccas JA
    Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
    Silva-Sánchez A; Meza-Pérez S; Flores-Langarica A; Donis-Maturano L; Estrada-García I; Calderón-Amador J; Hernández-Pando R; Idoyaga J; Steinman RM; Flores-Romo L
    PLoS One; 2015; 10(4):e0124828. PubMed ID: 25915045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection.
    Xue T; Stavropoulos E; Yang M; Ragno S; Vordermeier M; Chambers M; Hewinson G; Lowrie DB; Colston MJ; Tascon RE
    Infect Immun; 2004 Nov; 72(11):6324-9. PubMed ID: 15501761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.
    Tanghe A; Content J; Van Vooren JP; Portaels F; Huygen K
    Infect Immun; 2001 Sep; 69(9):5403-11. PubMed ID: 11500410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection.
    Ates LS; Sayes F; Frigui W; Ummels R; Damen MPM; Bottai D; Behr MA; van Heijst JWJ; Bitter W; Majlessi L; Brosch R
    PLoS Pathog; 2018 Jun; 14(6):e1007139. PubMed ID: 29912964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    Tkachuk AP; Gushchin VA; Potapov VD; Demidenko AV; Lunin VG; Gintsburg AL
    PLoS One; 2017; 12(4):e0176784. PubMed ID: 28453555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves.
    Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Hewinson RG; Vordermeier HM; Barnes SW; Federe GC; Walker JR; Glynne RJ; Hsu T; Weinrick B; Biermann K; Larsen MH; Jacobs WR
    Vaccine; 2009 Feb; 27(8):1201-9. PubMed ID: 19135497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency.
    Kong XF; Martinez-Barricarte R; Kennedy J; Mele F; Lazarov T; Deenick EK; Ma CS; Breton G; Lucero KB; Langlais D; Bousfiha A; Aytekin C; Markle J; Trouillet C; Jabot-Hanin F; Arlehamn CSL; Rao G; Picard C; Lasseau T; Latorre D; Hambleton S; Deswarte C; Itan Y; Abarca K; Moraes-Vasconcelos D; Ailal F; Ikinciogullari A; Dogu F; Benhsaien I; Sette A; Abel L; Boisson-Dupuis S; Schröder B; Nussenzweig MC; Liu K; Geissmann F; Tangye SG; Gros P; Sallusto F; Bustamante J; Casanova JL
    Nat Immunol; 2018 Sep; 19(9):973-985. PubMed ID: 30127434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes.
    Abolhassani M; Lagranderie M; Chavarot P; Balazuc AM; Marchal G
    Infect Immun; 2000 Oct; 68(10):5657-62. PubMed ID: 10992467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.